Astromech raises $20M to build a biological operating system that can forecast evolutionary change
$20M and a $3.8B valuation: Astromech's bet that AI can forecast evolutionary change is now a real commercial play.
Why it matters
A biotech-focused AI startup with serious institutional backing is pursuing predictive models for biological systems — signaling investor confidence in AI's role in life sciences and adding another data point to the AI funding landscape.
The key facts
12 to knowAstromech raised $20M Series funding
Post-money valuation: $3.8B
Lead investor: Bob Nelsen (biotech focused)
Other investors: Peak 6, NeoGenesis Capital, Builders VC, CAZ Investments
Company focus: AI models to predict biological/evolutionary change
Published: August 2026
Astromech raised $20M Series round
Valuation: $3.8B post-money
Led by biotech investor Bob Nelsen
Investors: Peak 6, NeoGenesis Capital, Builders VC, CAZ Investments
Focus: AI models for predicting biological/evolutionary change
Company positioning: 'biological operating system'
Go to the source
SiliconAnglesiliconangle.com
Publisher excerpt: An artificial intelligence startup called Astromech that’s developing models that can predict biological change has raised $20 million in funding, lifting its valuation to $3.8 billion. The round was led by biotechnology investor Bob Nelsen and saw the participation of Peak 6, NeoGenesis Capital,…